An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant Bacteria.

Huang, David B; Strader, Catherine D; MacDonald, James S; VanArendonk, Mark; Peck, Richard; Holland, Thomas

Huang, David B; Strader, Catherine D; MacDonald, James S; VanArendonk, Mark; Peck, Richard; Holland, Thomas.

Afiliação

Huang DB; Motif BioSciences, New York, New York; Rutgers New Jersey Medical School.
Strader CD; Synergy Partners R&D Solutions, Chester, New Jersey.
MacDonald JS; Synergy Partners R&D Solutions, Chester, New Jersey.
VanArendonk M; Vermeer Pharma, Morristown, New Jersey.
Peck R; Hemex, Liestal, Switzerland.
Holland T; Duke University Medical Center, Durham, North Carolina.

Open Forum Infect Dis ; 5(2): ofy003, 2018 Feb.

Article em En | MEDLINE | ID: mdl-29423421

Palavras-chave

bactericidal; iclaprim; multidrug-resistant bacteria; pneumonia; skin infections

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google